相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management
Shailja C. Shah et al.
GASTROENTEROLOGY (2022)
Low-dose aspirin use and cancer-specific mortality: a meta-analysis of cohort studies
Xianmin Wang et al.
JOURNAL OF PUBLIC HEALTH (2021)
Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease
Parita Patel et al.
INFLAMMATORY BOWEL DISEASES (2021)
Aspirin Use and Risk of Colorectal Cancer Among Older Adults
Chuan-Guo Guo et al.
JAMA ONCOLOGY (2021)
Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease
Shurong Hu et al.
FRONTIERS IN PSYCHIATRY (2021)
Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse
Pawel Kuznicki et al.
JOURNAL OF CLINICAL MEDICINE (2021)
A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration
P. Tavakoli et al.
PUBLIC HEALTH REVIEWS (2021)
The epidemiology of inflammatory bowel disease: East meets west
Wing Yan Mak et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sudabeh Alatab et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Anti-Inflammatory Drugs as Anticancer Agents
Silvia Zappavigna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
John Burn et al.
LANCET (2020)
Colorectal cancer in inflammatory bowel disease: review of the evidence
D. S. Keller et al.
TECHNIQUES IN COLOPROCTOLOGY (2019)
Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments
William T. Clarke et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Risks of colorectal neoplasms and cardiovascular thromboembolic events after the combined use of selective COX-2 inhibitors and aspirin with 5-year follow-up: a meta-analysis
P. He et al.
COLORECTAL DISEASE (2019)
The role of interleukin-1 in general pathology
Naoe Kaneko et al.
INFLAMMATION AND REGENERATION (2019)
Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation
O. O. Moninuola et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis
Xinyun Qiu et al.
ONCOTARGET (2017)
Crohn Disease: Epidemiology, Diagnosis, and Management
Joseph D. Feuerstein et al.
MAYO CLINIC PROCEEDINGS (2017)
Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention
Argentina Ornelas et al.
CANCER AND METASTASIS REVIEWS (2017)
Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease
S. Bonovas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease
Millie D. Long et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial
Patricia A. Thompson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
Jordan E. Axelrad et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
Nick E. Burr et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial
Patricia A. Thompson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants
Hongmei Nan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease
Charlotte L. Kvasnovsky et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
Rikke Norregaard et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2015)
Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach
Edoardo Aromataris et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study
Abigail Hensley et al.
PHARMACEUTICALS (2015)
NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: Haplotype associations and gene-environment interactions
Andrea Y. Angstadt et al.
GENES CHROMOSOMES & CANCER (2014)
Critical Review of the Evidence on 5-Aminosalicilate for Chemoprevention of Colorectal Cancer in Ulcerative Colitis: A Methodological Question
Giovanna Margagnoni et al.
CURRENT CLINICAL PHARMACOLOGY (2014)
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs
Barbara Rolando et al.
CHEMMEDCHEM (2013)
Platelet Abnormalities during Colonic Inflammation
Serena L. S. Yan et al.
INFLAMMATORY BOWEL DISEASES (2013)
Microscopic colitis. A review
William R. Brown et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
Extraintestinal manifestations and complications in IBD
Claudia Ott et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis A Cohort Study
Ashwin N. Ananthakrishnan et al.
ANNALS OF INTERNAL MEDICINE (2012)
Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk?
Jessica K. Dyson et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study
S. S. M. Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Farhat V. N. Din et al.
GUT (2010)
Age Distribution of IBD Hospitalization
Amnon Sonnenberg
INFLAMMATORY BOWEL DISEASES (2010)
Gastroduodenal Mucosal Injury in Patients Taking Low-Dose Aspirin and the Role of Gastric Mucoprotective Drugs: Possible Effect of Rebamipide
Takatsugu Yamamoto et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2010)
Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?
Helenie Kefalakes et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Novel agents for cancer prevention based on nitric oxide
B. Rigas
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Chemoprevention for colon cancer: New opportunities, fact or fiction?
J. S. Terhaar Sive Droste et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Chemoprevention: Risk reduction with medical therapy of inflammatory bowel disease
Erick P. Chan et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2006)
Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress
JJ Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
TP van Staa et al.
GUT (2005)
5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease
Yang Cheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer
RD Church et al.
BRITISH JOURNAL OF CANCER (2004)
Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation
JL Wallace et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
RK Yeh et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Rapid development of colitis in NSAID-treated IL-10-deficient mice
DJ Berg et al.
GASTROENTEROLOGY (2002)
Nitric oxide-releasing NSAIDs - A review of their current status
S Fiorucci et al.
DRUG SAFETY (2001)
Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats
K Tashima et al.
LIFE SCIENCES (2000)
分享论文
